Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sorenson Ventures is the early-stage venture investing arm/brand of Sorenson Capital, a private venture capital firm focused primarily on enterprise software, cybersecurity, developer tools, infrastructure, data, and AI-related companies. It is not a drug developer, healthcare operator, or life sciences company. The firm appears active and continues to operate under the broader Sorenson Capital platform, including more recent references to "Ventures III" as an early-stage fund. For biotech or pharma diligence purposes, Sorenson Ventures is best categorized as an investor rather than an operating healthcare company, and there is no evidence that it runs a therapeutic pipeline or commercial healthcare products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sorenson Ventures.